Metastatic pancreatic cancer 2008: is the glass less empty?
about
Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancerTargeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres FormationEnzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinomaMolecular imaging in pancreatic cancer--a roadmap for therapeutic decisions.Vascularisation pattern of chronic pancreatitis compared with pancreatic carcinoma: results from contrast-enhanced endoscopic ultrasound.DNA methyltransferases: a novel target for prevention and therapy.Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancerSurvival prediction for pancreatic cancer patients receiving gemcitabine treatment.RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells.Cancer stem cells: a novel paradigm for cancer prevention and treatment.Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarrayRexin-G, a targeted genetic medicine for cancer.Current and emerging therapies for the treatment of pancreatic cancer.Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed micePancreatic resections for advanced M1-pancreatic carcinoma: the value of synchronous metastasectomy.Knockdown of snail sensitizes pancreatic cancer cells to chemotherapeutic agents and irradiationAberrant expression of microRNAs in serum may identify individuals with pancreatic cancer.Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesisIncreased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma.Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasisRegulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention.Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancerCDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis.Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancerA novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer.Vitamin D receptor signaling and pancreatic cancer cell EMT.Efficacy of contrast-enhanced harmonic endoscopic ultrasonography in the diagnosis of pancreatic ductal carcinomaDysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid.FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator systemNeurotransmitter receptors as central regulators of pancreatic cancerHS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1.Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.GABA (γ-aminobutyric acid), a non-protein amino acid counters the β-adrenergic cascade-activated oncogenic signaling in pancreatic cancer: a review of experimental evidence.A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services.Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer.
P2860
Q24631880-FD01D002-1CB0-4B05-A4DF-E3AC788A4363Q28552789-B056DDE9-60AF-46BF-95C9-AB6CC47D3E90Q29616287-9EF6ACE1-CEB9-4E49-93E6-E55BB28B11EEQ30423854-93C34FAE-E9DD-4549-879A-72B2DEDC8FEBQ30465459-A38305D9-A988-4B1E-AC0E-BCBB9574EFFFQ33579896-5203FA4F-7B96-44C8-8DAA-06DBFD723BF9Q33730750-83693007-7CBB-4060-A89C-7477A0F6CE14Q33812871-36152B38-316E-4916-B94C-6F32071FD8B3Q33828424-B6AED1F2-516A-4C79-89E8-2E260BFE928BQ33867131-DDCA91F3-60AD-4AAC-8E90-8E8B74AE9D37Q34039390-509D0504-7C25-41F2-9857-7E61777D1CA2Q34109646-C1CAAE4D-8E8A-4A01-9992-1841B2806F5DQ34129346-E0D19108-1518-4540-A72A-57F3ECE20D77Q34391552-C04D6B51-6A79-4FD4-B72D-3A54D0AA5DFDQ34442561-873CF3AD-E437-4787-A4F1-DA20D2674870Q35002139-55534264-07A2-4C03-8699-D96CE8577971Q35017119-158E8655-9414-4F31-A087-020784EBB57EQ35142413-4C36410A-B7AB-4E6E-BF3F-D3B7BD64D6C5Q35541678-5E89869B-109D-4492-9D5F-70BFD4B29780Q35555982-9B881ED5-B553-4D08-8A99-91653D1E8589Q35719620-DFDE3880-3360-4ADF-A532-D880C7FB9DEFQ35729454-B1303BA0-6E5F-4C7F-BDBD-C4F2E4A6362AQ35747302-9A2D8750-C2EE-44BB-966D-57E5A8DF9770Q36058012-5C79F7E4-0DB2-4138-AB42-4E7F203DA857Q36084097-52C74441-F1B9-418D-A6B9-AF645B7D5542Q36351453-F3F21991-C7C4-4176-9BD3-A761580FC38AQ36776472-87C69819-768B-4049-8A44-F5C9B84474ECQ36935182-AD75CAF3-7AEB-46EA-80E7-7E5AFD260828Q36981321-477E14C3-6AD4-46EB-9450-14F62C5B7387Q36986150-9F8811CF-C95C-4960-B22C-227BA97FD49CQ37174016-2B5EEB09-3E60-406F-BBC8-1FB7A7B2CECEQ37292726-19FFDCEB-413A-49D5-BBD1-4479E944896FQ37646911-66E4FE44-9684-42D9-9F98-9941D0DC7A65Q37690295-9C952764-386A-4BFB-8DC7-3F4B9B55018BQ37718484-F5180ADE-183E-4002-96E3-4EFFAD7AEAB6Q37734872-BAE1671F-679E-4ADC-930E-1CA78A9AE04EQ37824829-910FCD51-6535-4041-AE6F-198F1C948963Q37909261-EBC79A1E-E621-4516-B3E9-68C034870D45Q38989980-DA3992EF-53A7-4B1B-9350-49B490C982F0Q39001305-DCC194D8-A474-495F-AD53-A70EE1EF2796
P2860
Metastatic pancreatic cancer 2008: is the glass less empty?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metastatic pancreatic cancer 2008: is the glass less empty?
@en
Metastatic pancreatic cancer 2008: is the glass less empty?
@nl
type
label
Metastatic pancreatic cancer 2008: is the glass less empty?
@en
Metastatic pancreatic cancer 2008: is the glass less empty?
@nl
prefLabel
Metastatic pancreatic cancer 2008: is the glass less empty?
@en
Metastatic pancreatic cancer 2008: is the glass less empty?
@nl
P2093
P1433
P1476
Metastatic pancreatic cancer 2008: is the glass less empty?
@en
P2093
Jacqueline Nieto
Michael L Grossbard
Peter Kozuch
P304
P356
10.1634/THEONCOLOGIST.2007-0181
P577
2008-05-01T00:00:00Z